Globus Medical, Inc.

193 articles about Globus Medical, Inc.

• Globus Medical Reports Fourth Quarter and Full Year 2023 Results

  2/20/2024

  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023.

• Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

  2/13/2024

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024.

• Globus Medical Reports Third Quarter 2023 Results

  11/7/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended September 30, 2023.

• Globus Medical Schedules 2023 Third Quarter Earnings Release and Conference Call

  10/24/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2023 after the market close on Tuesday, November 7, 2023.

• Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting

  10/24/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, presented five-year outcomes from the NuVasive Simplify Cervical Disc study at the North American Spine Society 38th Annual Meeting.

• Globus Medical Completes Merger with NuVasive

  9/1/2023

  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc.

• Globus Medical Reports Second Quarter 2023 Results

  8/3/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended June 30, 2023.

• Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis

  7/31/2023

  Globus Medical, Inc. announced the commercial launch of the MARVEL™ Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain correction while allowing for growth through minimally invasive distraction.

• Globus Medical Schedules Second Quarter 2023 Earnings Release and Conference Call

  7/13/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 3, 2023.

• Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis

  5/15/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced the REFLECT™ Scoliosis Correction System has been granted approval from the US Food and Drug Administration, as the company’s first humanitarian device.

• Globus Medical Reports First Quarter 2023 Results

  5/4/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended March 31, 2023.

• Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

  4/27/2023

  Globus Medical, Inc. announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive.

• Globus Medical Schedules First Quarter 2023 Earnings Release and Conference Call

  4/19/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023.

• Globus Medical Reports Fourth Quarter and Full Year 2022 Results

  2/21/2023

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the fourth quarter and year ended December 31, 2022.

• Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

  2/9/2023

  Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction.

• Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

  2/2/2023

  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023.

• Globus Medical Reports Third Quarter 2022 Results

  11/8/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended September 30, 2022.

• Globus Medical Schedules Third Quarter Earnings 2022 Release and Conference Call

  10/19/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2022 after the market close on Tuesday, November 8, 2022.

• Globus Medical Reports Second Quarter 2022 Results

  8/4/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended June 30, 2022.

• Globus Medical Schedules 2022 Second Quarter Earnings Release and Conference Call

  7/18/2022

  Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 4, 2022.